## LH: Labcorp Holdings Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($255.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Scotia Capital Inc. Has $17.33 Million Holdings in Labcorp Holdings Inc. $LH**
- Source: MarketBeat | 20251130T120655 | Somewhat-Bullish | Relevance: 99%
- Scotia Capital Inc. significantly reduced its stake in Labcorp Holdings Inc. ($LH) by 39.4% in Q2, now holding 66,028 shares valued at approximately $17.33 million. Despite insider selling by executives like CEO Adam Schechter, Labcorp exceeded Q3 EPS expectations, provided strong FY2025 guidance, and announced a quarterly dividend. The company maintains a "Moderate Buy" consensus rating from analysts with an average target price of around $297.

**2. Choreo LLC Boosts Stock Position in Labcorp Holdings Inc. $LH**
- Source: MarketBeat | 20251201T085514 | Neutral | Relevance: 98%
- Choreo LLC increased its stake in Labcorp Holdings Inc. (NYSE:LH) by 83.8% in Q2, bringing their total holdings to 5,546 shares valued at $1.456 million. Despite institutional ownership reaching 95.94%, significant insider selling by Director Richelle Parham and CEO Adam Schechter has reduced insider ownership to 0.84%. Analysts currently have a consensus "Moderate Buy" rating for Labcorp, with an average target price of $297.07, and the company recently announced a quarterly dividend of $0.72 per share.

**3. Franklin Resources Inc. Purchases 1,043 Shares of Labcorp Holdings Inc. $LH**
- Source: MarketBeat | 20251201T093630 | Bullish | Relevance: 97%
- Franklin Resources Inc. significantly increased its stake in Labcorp Holdings Inc. by purchasing an additional 1,043 shares, bringing its total holdings to 34,331 shares valued at approximately $9.01 million. Several other institutional investors also materially increased their positions, raising institutional ownership to about 95.94%, despite recent insider selling by Labcorp's CEO and a director. Labcorp reported an EPS beat, provided solid FY2025 guidance, and announced a quarterly dividend, while analysts maintain a "Moderate Buy" rating for the stock.

**4. Charles River Laboratories International Inc. stock outperforms competitors on strong trading day**
- Source: MSN | 20251201T090555 | Somewhat-Bullish | Relevance: 74%
- Charles River Laboratories International Inc. (CRL) shares rose 1.83% to $201.20 on Tuesday, outperforming competitors and the broader market. Despite this daily gain, the stock has seen a significant year-to-date decline of 14.86%, contrasting with the S&P 500's 18.06% increase.

**5. Quest Diagnostics, Octave Collaborate to Expand Multiple Sclerosis Disease Activity Test Access**
- Source: MarketScreener | 20251201T153300 | Neutral | Relevance: 71%
- Quest Diagnostics and Octave Bioscience have announced a collaboration to broaden access to Octave's Multiple Sclerosis Disease Activity Test across the United States. This partnership aims to make advanced diagnostic testing more widely available for individuals with multiple sclerosis.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 5 ($3.37M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-0.7%)
- Blackrock Inc.: 9.8% (-10.3%)
- State Street Corpora: 4.6% (-0.8%)
- Victory Capital Mana: 3.2% (+20.0%)
- JPMORGAN CHASE & CO: 2.6% (+64.8%)

### Key Risks

1. Insider selling cluster: $3.4M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.94 indicates undervaluation relative to growth. Forward P/E 15.3x stretched relative to 7% growth. Insider selling cluster ($3.4M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $21.8B |
| Beta | 0.96 |
| 52W Range | $209.38 - $293.72 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.94 |
| Forward P/E | 15.3 |
| Current P/E | 16.4 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). MACD histogram positive (1.44), confirming momentum. RSI neutral at 52.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.03% (CS: 43) | Neutral |
| RSI_14 | 52.3 | Neutral |
| MACD Histogram | 1.44 | Bullish |
| vs SMA20 | 1.022x | Above |
| vs SMA50 | 0.988x | Below |
| vs SMA200 | 1.042x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $267.73
- **Stop Loss:** $255.53 (4.6% risk)
- **Target:** $279.93 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 61
- **Position Value:** $16,331.53
- **Portfolio %:** 16.33%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

### Earnings

**Next:** 2026-02-05 (Est: $3.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.14 | $4.18 | +1.0% |
| 2025Q2 | $4.18 | $4.35 | +4.1% |
| 2025Q1 | $3.73 | $3.84 | +2.8% |
| 2024Q4 | $3.39 | $3.45 | +1.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*